Holy Basil in The Treatment of Dyspepsia
Recruiting
Phase 2
Phase 3
Interventional Study
Dyspepsia and Other Specified Disorders of Function of Stomach
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 2/3
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 27 (estimated)
- Sponsor
- Mahidol University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to evaluate whether holy basil extract can reduce gastric inflammation and improve symptoms in adult patients with dyspepsia.
The main questions it aims to answer are:
* Does holy basil extract reduce gastric mucosal inflammation as measured by histopathology?
* Does holy basil extract improve dyspeptic symptoms, endoscopic findings, gastric pH, duodenal eosino…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Participants aged 18 years and older.
* Presence of dyspeptic symptoms, assessed by the Leeds Dyspepsia Questionnaire with a score of at least 5 or higher.
Exclusion Criteria:
* Presence of Helicobacter pylori infection.
* Diagnosis of peptic ulcer or erosive esophagitis Los…
Contacts